7 Most Profitable Value Stocks to Buy Right Now

Page 2 of 2

6. GSK plc (NYSE:GSK)

GSK plc (NYSE:GSK) is one of the most profitable value stocks to buy right now. On March 13, GSK plc announced that the US FDA expanded the approved age indication for its RSV vaccine, AREXVY. The vaccine is now authorized for adults aged 18 to 49 who are at an increased risk for lower respiratory tract disease/LRTD caused by respiratory syncytial virus. This decision follows previous approvals for adults aged 60 and older, as well as those aged 50 to 59 with specific risk factors, though the vaccine remains restricted from use in pregnant individuals.

The FDA expansion is supported by data from a Phase IIIb trial, which showed a non-inferior immune response in the 18 to 49 age group compared to adults aged 60 and older. The safety profile remained consistent with earlier clinical programs, with common side effects including injection site pain, fatigue, and headache. GSK highlighted that this approval addresses a significant medical need, as ~21 million US adults under 50 have at least one risk factor, such as chronic kidney disease, diabetes, or obesity, that increases the likelihood of severe RSV infection.

The annual burden of RSV in the US for adults under 50 includes ~17,000 hospitalizations and ~2 million outpatient visits. GSK executives stated that broadening access to the vaccine will help mitigate these outcomes and reduce pressure on the healthcare system. While the vaccine is now approved for this younger demographic in the US and the European Economic Area, GSK is continuing to pursue further regulatory submissions globally to support its long-term growth objectives for the product.

GSK plc (NYSE:GSK) is a drug manufacturer that specializes in vaccines, specialty medicines, and general medicines to prevent and treat various diseases through its Commercial Operations and Total R&D segments.

While we acknowledge the potential of GSK to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than GSK and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the 5 Most Profitable Value Stocks to Buy Right Now.

Disclosure: None. None. Follow Insider Monkey on Google News.

Page 2 of 2